查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
導管市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)
市場調查報告書
商品編碼
1190244

導管市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Catheters Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內 (2022-2027)，導管市場預計將以 7.7% 的複合年增長率增長。

隨著 COVID-19 病例數量的增加和世界各地出現封鎖條件，治療、診斷和手術等服務最初被擱置以防止 COVID-19 的傳播並進入市場。它有一個大的影響。 然而，全球 COVID-19 病例數量的增加導致住院人數增加。 隨著政府和醫療機構發現更有效的醫療服務來治療 COVID-19 患者，導管的使用在醫院和急診室顯示出巨大的需求。 疑似或確診 COVID-19 的患者使用導管進行治療，在大流行期間對這些產品的需求仍然巨大。 此外，預計在大流行期間推出產品也將對市場增長產生積極影響。 例如，2020 年 4 月，Bactiguard 宣布推出一種新型導尿管 BIP Foley TempSensor，用於對患者進行持續體溫監測。 這些因素共同推動了大流行期間的市場增長。

由於心血管、神經和泌尿系統疾病的負擔不斷增加，微創手術的使用越來越多，以及對抗菌導管的需求不斷增加，預計該市場將經歷良好的增長。 不斷增加的慢性病是全球死亡率和發病率的主要原因。 根據腦動脈瘤基金會 2021 年 3 月的數據，全球每年約有 50 萬人死於腦動脈瘤，其中一半年齡在 50 歲以下。 年破裂率約為每 100,000 人 8 至 10 人，或在美國約為 30,000 人。 因此，神經血管導管裝置的需求預計會隨著神經血管疾病的增加而增加。

此外，微創手術的增加預計將增加全球對導管的需求。 這些手術增加了患者對微創手術的偏好，預計這將有利於市場的增長。 此外，主要市場參與者加大力度推出產品，預計將進一步推動市場增長。 例如，2021年7月，美敦力公司在獲得CE（Conformite Europeenne）標誌後，在歐洲推出了Prevail藥物塗層球囊（DCB）導管。 市場上最新的冠狀動脈 DCB，Prevail DCB，用於經皮冠狀動脈介入治療 (PCI) 手術，以治療冠狀動脈疾病 (CAD) 患者的冠狀動脈狹窄或阻塞。 這將增加採用此類導管治療心血管疾病，市場增長將受益於微創手術的上升趨勢。

因此，隨著慢性病病例的增加，手術數量的增加，預計在不久的將來對導管的需求將增加，從而推動市場的增長。 然而，與導管相關的並發症和替代品的存在可能會阻礙市場增長。

主要市場趨勢

在預測期內，導尿管板塊有望對收益和預測產生重大影響

當自主排尿困難時，需要導尿管。 由於泌尿系統疾病的患者使用該產品，因此泌尿系統疾病的發病率不斷增加，預計該產品在預測期內將呈現高增長。

COVID-19 病例數量的增加在全球範圍內造成了嚴重的破壞，並且還影響了患者群體對導尿管的需求。 導尿管用於外科手術，由於當局試圖為 COVID-19 患者預留資源，各種擇期手術被暫時推遲，一定程度上影響了需求。 然而，不斷上升的感染率導致推出了幾種產品，這些產品有助於該細分市場的穩定增長。 此外，根據 2020 年 10 月發表的一項題為“中國女性尿失禁患病率及相關因素：文獻綜述”的研究，有 43 至 349 名中國女性患有尿失禁 (UI)。估計達到 10,000人們。 尿失禁患病率的上升和外科手術的增加是推動導尿管需求的主要因素，這反過來又促進了這一領域的增長。

此外，預計在預測期內，導尿管監管審批的增加將進一步推動該細分市場的增長。 例如，2021 年 11 月，Flume Catheter Company Ltd. (TFCC) 獲得美國食品藥品監督管理局 (FDA) 的批准，可以在美國銷售 FLUME 導尿管。

因此，由於上述因素，預計泌尿外科導管部分在預測期內將呈現增長。

預計在預測期內北美將佔據較大的市場份額

在預測期內，北美地區預計將在導管市場佔據重要的市場份額。 由於政府對醫療設備的高度支持和手術數量的增加，預計美國將主導市場。 推動市場增長的其他因素包括泌尿系統和心血管疾病的增加，以及由於手術時間更短和並發症更少而越來越傾向於微創手術。

根據美國癌症協會2022年的統計數據，估計2022年美國人將有大約81,180例膀胱癌新發病例。 預計這將增加導管在膀胱癌治療中的應用，推動該地區的市場增長。

主要市場參與者對新產品發布的更多承諾預計也將進一步推動該地區的市場。 例如，2022年3月，Cerus Endovascular的027微導管獲得了美國食品藥品監督管理局（FDA）的批准，該微導管有兩種長度可供選擇，並且包括已經獲得FDA批准的021微導管平台，公司的產品組合得到了擴展。 同樣，2021 年 2 月，加拿大衛生部批准了 Bactguard 設計的 TempSensor 導管。

因此，擴大產品批准，加上美國患者人數的急劇增加，往往會增加對導管的需求，從而推動該地區的整體市場增長。

競爭格局

導管市場競爭激烈，許多公司都專注於開發先進的導管。 許多製造商與領先的醫療設備分銷商合作，在全球或選定的國家/地區營銷和分銷他們的產品。 各種現有企業也採用了一些有機和無機增長戰略來增加他們的市場份額。 此外，產品發布、併購和合作是這些公司為實現持續增長而採取的主要戰略。 該市場的主要參與者包括 B. Braun Melsungen AG、Coloplast、ConvaTec Group、Hollister Incorporated、Medtronic PLC、Teleflex 和 Boston Scientific Corporation。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 增加心血管、神經和泌尿系統疾病的負擔
    • 微創手術的使用增加
    • 對抗菌導管的需求不斷增長
  • 市場製約因素
    • 與導管相關的風險和並發症
    • 存在替代方案
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按產品分類
    • 心血管導管
    • 泌尿導管
    • 靜脈導管
    • 神經血管導管
    • 其他產品
  • 最終用戶
    • 醫院
    • 療養院
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • B. Braun Melsungen AG
    • Coloplast
    • ConvaTec Group□
    • Hollister Incorporated
    • Medtronic PLC
    • Teleflex
    • Boston Scientific Corporation
    • Biotronik
    • Abbott Laboratories
    • Edwards Lifesciences Corporation
    • Johnson & Johnson（DePuy Synthes）
    • Terumo Corporation
    • Becton, Dickinson and Company（C.R. Bard）

第7章 市場機會與今後動向

簡介目錄
Product Code: 67961

The Catheters Market is poised to register a CAGR of 7.7% during the forecast period (2022-2027).

The rising COVID-19 cases across the world and the lockdown situation have had a significant impact on the market, initially due to on-hold services, such as treatment, diagnostic, and surgical services, to prevent the spread of COVID-19. However, the growing number of COVID-19 cases around the world has helped in increasing the number of in-patient admissions. As governments and healthcare institutions were found to increase efficient medical treatment to treat COVID-19 patients, the usage of catheters witnessed tremendous demand in hospitals and emergency clinics. Patients with suspected or confirmed diagnoses of COVID-19 were being treated with the help of catheters, and hence, the demand for these products remained huge throughout the pandemic. Moreover, product launches amid the pandemic were also anticipated to have a positive impact on the market's growth. For instance, in April 2020, Bactiguard introduced a new urinary catheter, the BIP Foley TempSensor, for continuous temperature monitoring in patients. Such factors collectively bolstered the market's growth over the pandemic phase.

The market is expected to observe good growth due to the increasing burden of cardiovascular, neurologic, and urological disorders; increasing usage of minimally invasive procedures; and the rising demand for antimicrobial catheters. Rising chronic disorders have become the most dominant cause of mortality and morbidity globally. According to the Brain Aneurysm Foundation in March 2021, globally, approximately 500,000 deaths are caused by brain aneurysms every year, and half of such individuals are aged 50 or below. The annual rate of rupture is around 8-10 people per 100,000 or about 30,000 people in United States. Thus, with the increasing prevalence of neurovascular disorders, the demand for neurovascular catheter devices is also anticipated to rise.

Furthermore, the growing number of minimally invasive procedures is expected to increase the demand for catheters worldwide. These procedures have increased patients' preference for less invasive procedures, which is expected to favor the market's growth. In addition, rising initiatives from the key market players for the launch of their products are expected to propel the market's growth further. For instance, in July 2021, Medtronic plc launched its Prevail drug-coated balloon (DCB) catheter in Europe following the CE (Conformite Europeenne) mark. The newest coronary DCB on the market, the Prevail DCB, is used during percutaneous coronary intervention (PCI) procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease (CAD). This will lead to increased adoption of such catheters to treat cardiovascular disease, and the market growth will benefit from rising minimally invasive procedure trends.

Hence, with the increasing number of surgeries being performed due to rising cases of chronic diseases, the demand for catheters is expected to increase in the near future, thereby driving the market's growth. However, complications associated with catheters and the presence of substitutes may hamper the growth of the market.

Key Market Trends

The Urology Catheters Segment is Expected to Hold a Major Revenue Share During the Forecast Period

A urinary catheter is found to be necessary for a person facing difficulty passing urine naturally. The segment is expected to show high growth during the forecast period owing to growing incidences of urological disorders as these products are used for patients who suffer from urological disorders.

The rising cases of COVID-19 have resulted in significant disruptions globally and have also impacted the demand for urinary catheters among the patient population. The urinary catheters were being used for surgical applications and the demand was impacted to some extent due to the temporary postponement of various elective surgeries, as authorities seek to ensure the availability of resources for COVID-19 patients. However, due to the rising infection rate, there were a few launches that have contributed to the segment's stable growth. Furthermore, according to the study titled "Prevalence and associated factors of urinary incontinence in women living in China: a literature review" published in October 2020, there were about 43-349 million Chinese women who had experienced urinary incontinence (UI). The growing prevalence of urinary incontinence and an increasing number of surgical procedures are the major factors driving the demand for urinary catheters, in turn boosting the segment's growth.

In addition, rising approvals for urinary catheters by regulatory agencies are further expected to boost this segment's growth during the forecast period. For instance, in November 2021, the Flume Catheter Company Ltd. (TFCC) received clearance from United States Food and Drug Administration (FDA) to market the FLUME urinary catheter in United States.

Thus, owing to the abovementioned factors, the urology catheter segment is expected to show growth over the forecast period.

North America is Expected to Hold a Significant Market Share During the Forecast Period

The North American region is expected to hold a significant market share in the catheters market during the forecast period. United States is expected to dominate the market due to the high government support for medical devices and an increasing number of surgeries. The other factors driving the market growth include the increasing prevalence of urological disorders, cardiovascular disorders, and the rising preference for minimally invasive procedures due to less operative time and fewer complications.

According to the American Cancer Society's 2022 statistics, there will be around 81,180 estimated new cases of bladder cancer in Americans in the year 2022. This will lead to increased adoption of catheters during the treatment of bladder cancer, thereby driving the market growth in this region.

Rising initiatives from the key market players for the launch of novel products are further expected to drive the market in this region. For instance, in March 2022, Cerus Endovascular received United States Food and Drug Administration (FDA) clearance for its 027 micro-catheters, available in two lengths, expanding its product portfolio, which includes the already FDA-cleared 021 micro-catheter platform. Likewise, in February 2021, Health Canada approved the TempSensor catheter designed by Bactguard.

Hence, growing product approvals coupled with the rapid increase in the patient pool in United States tend to increase the demand for catheters, which drives the overall growth of the market in the region.

Competitive Landscape

The catheters market is highly competitive as there have been a wide number of companies that have increased their focus on developing advanced catheters. Numerous manufacturers have collaborated with major medical device distributors to market and supply their products globally or in certain countries. Various established business players are also adopting numerous organic and inorganic growth strategies to increase their market shares. Also, product launches, mergers and acquisitions, and collaborations are the key strategies undertaken by these companies for sustainable growth. Some of the major players in this market include B. Braun Melsungen AG, Coloplast, ConvaTec Group, Hollister Incorporated, Medtronic PLC, Teleflex, and Boston Scientific Corporation, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Cardiovascular, Neurological, and Urological Disorders
    • 4.2.2 Increasing Usage of Minimally Invasive Procedures
    • 4.2.3 Rising Demand for Antimicrobial Catheters
  • 4.3 Market Restraints
    • 4.3.1 Risks and Complications Associated with Catheters
    • 4.3.2 Presence of Substitutes
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Cardiovascular Catheters
    • 5.1.2 Urology Catheters
    • 5.1.3 Intravenous Catheters
    • 5.1.4 Neurovascular Catheters
    • 5.1.5 Other Products
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Long Term Care Facilities​
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 B. Braun Melsungen AG
    • 6.1.2 Coloplast
    • 6.1.3 ConvaTec Group​
    • 6.1.4 Hollister Incorporated
    • 6.1.5 Medtronic PLC
    • 6.1.6 Teleflex
    • 6.1.7 Boston Scientific Corporation
    • 6.1.8 Biotronik
    • 6.1.9 Abbott Laboratories
    • 6.1.10 Edwards Lifesciences Corporation
    • 6.1.11 Johnson & Johnson (DePuy Synthes)
    • 6.1.12 Terumo Corporation
    • 6.1.13 Becton, Dickinson and Company (C.R. Bard)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS